Ak Jensen Investment Managemen Acquires 70,000 Shares of ASP Isotopes Inc. (NASDAQ:ASPI) Stock

ASP Isotopes Inc. (NASDAQ:ASPIGet Free Report) major shareholder Ak Jensen Investment Managemen bought 70,000 shares of the stock in a transaction dated Monday, July 8th. The shares were purchased at an average price of $3.05 per share, with a total value of $213,500.00. Following the completion of the transaction, the insider now directly owns 6,586,874 shares in the company, valued at approximately $20,089,965.70. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Large shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

Ak Jensen Investment Managemen also recently made the following trade(s):

  • On Wednesday, July 10th, Ak Jensen Investment Managemen acquired 61,849 shares of ASP Isotopes stock. The shares were acquired at an average price of $3.40 per share, with a total value of $210,286.60.

ASP Isotopes Price Performance

NASDAQ:ASPI opened at $3.47 on Friday. The firm has a market capitalization of $179.62 million, a price-to-earnings ratio of -6.55 and a beta of 5.12. The company has a debt-to-equity ratio of 1.70, a current ratio of 3.57 and a quick ratio of 3.57. The business has a 50 day simple moving average of $3.98 and a 200-day simple moving average of $3.41. ASP Isotopes Inc. has a 1 year low of $0.58 and a 1 year high of $5.67.

ASP Isotopes (NASDAQ:ASPIGet Free Report) last announced its earnings results on Wednesday, May 15th. The company reported ($0.16) earnings per share for the quarter. The firm had revenue of $0.84 million for the quarter. Equities analysts forecast that ASP Isotopes Inc. will post -0.11 EPS for the current year.

Wall Street Analyst Weigh In

Separately, HC Wainwright upped their target price on shares of ASP Isotopes from $5.25 to $5.50 and gave the company a “buy” rating in a research report on Wednesday, April 17th.

View Our Latest Stock Report on ASPI

Institutional Investors Weigh In On ASP Isotopes

Large investors have recently added to or reduced their stakes in the stock. HTLF Bank purchased a new stake in shares of ASP Isotopes in the fourth quarter valued at approximately $141,000. Rathbones Group PLC bought a new stake in shares of ASP Isotopes in the fourth quarter valued at about $272,000. Vanguard Group Inc. grew its holdings in ASP Isotopes by 479.1% during the 1st quarter. Vanguard Group Inc. now owns 1,021,019 shares of the company’s stock worth $4,217,000 after acquiring an additional 844,705 shares in the last quarter. Finally, Virtu Financial LLC grew its holdings in ASP Isotopes by 477.0% during the 1st quarter. Virtu Financial LLC now owns 83,677 shares of the company’s stock worth $346,000 after acquiring an additional 69,176 shares in the last quarter. 16.80% of the stock is owned by hedge funds and other institutional investors.

About ASP Isotopes

(Get Free Report)

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.

Read More

Insider Buying and Selling by Quarter for ASP Isotopes (NASDAQ:ASPI)

Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.